J.Jill raises outlook after Q2 sales growth
J.Jill (NYSE:JILL) reported second quarter fiscal 2026 net sales of $154.8 million, up 0.5% year over year, and raised its fiscal 2026 outlook.
J.Jill (NYSE:JILL) reported second quarter fiscal 2026 net sales of $154.8 million, up 0.5% year over year, and raised its fiscal 2026 outlook.
Caleres (NYSE:CAL) reported second quarter 2026 net sales of $695.5 million, increasing 5.6% year over year as growth in its Brand Portfolio offset lower Famous Footwear sales.
Flotek (NYSE:FTK) raised its 2026 financial guidance, expecting total revenue of $360 million–$370 million and adjusted EBITDA of $50 million–$54 million.
CGI (NYSE:GIB) completed its acquisition of technology consulting firm Callibrity on September 8, 2026, to expand its commercial footprint in Cincinnati.
Sysco (NYSE:SYY) launched an artificial intelligence efficiency program targeting $500 million in savings by fiscal 2029.
AEVEX (NYSE:AVEX) secured $20.5 million in new awards to deliver one-way attack systems and expand operational capabilities for United States government customers.
KBR (NYSE:KBR) secured a new three-year Time and Materials contract to provide radio frequency engineering for a United States government customer.
Independence Realty Trust (NYSE:IRT) and Centerspace (NYSE:CSR) entered into a definitive all-stock merger agreement to create a combined residential real estate portfolio with an estimated enterprise value of $8.1 billion.
IDEAYA Biosciences (NASDAQ:IDYA) dosed the first patient in its Phase 3 OptimUM-11 trial to evaluate darovasertib as a first-in-class adjuvant therapy for primary uveal melanoma.
Brent crude futures rose above $100 a barrel on Wednesday for the first time since July 24 as escalating Middle East conflict increased concerns about regional oil supply disruptions.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy